1. Programmed Cell Death Is Necessary for Participation in the Regulatory Mechanism of Silicosis
Silicosis is a devastating interstitial lung disease characterized by silicon nodules and diffuse pulmonary fibrosis. It is a severe occupational hazard disease worldwide caused by long-term inhalation of crystalline-free silica dust in the workplaces (referred to as silica after this) [1,2]. Programmed cell death (PCD) refers to an active cell death process to maintain the internal environment’s stability after receiving a specific signal or stimulating factors [3]. Typical forms of PCD include autophagy, apoptosis, or pyrolysis, etc. [4]. Currently, increasing evidence has shown that PCD performs a necessary role in the pathogenesis of silicosis.
1.1. Silicosis Is a Complex Occupational Hazard Disease Worldwide
The current widely accepted silicosis pathogenesis is as follows: (1) Silica is identified and then phagocytosed by the alveolar macrophage (AM) via the scavenger receptor, which is the first critical defensive line for silica invasion [5,6]. Silicosis is developed through a vicious circle. AM engulfs silica to cause AM death and then releases intracellular silica that is further taken up by other AMs [7,8]; (2) Silicic acid produced by dissolved silica destroys the stability of the AM lysosomal membrane. Hydrolase released by the disrupted lysosome penetrates the cytoplasm overly and ultimately leads to AM death [9,10,11]; (3) Dead AMs can release a series of inflammatory factors, causing pulmonary inflammatory damage [12]. Correspondingly, AMs gather at the injured pulmonary tissue and stimulate fibroblasts to transform into myofibroblasts, leading to excessive deposition of the extracellular matrix and eventual silicosis fibrosis [13,14,15]. These steps are not necessarily executed in order or parallel strictly, and they are interspersed and connected to cause silicotic fibrosis.
1.2. Programmed Death of Various Types of Cells Has Different Significance for the Occurrence and Development of Silicosis
As mentioned above, transforming growth factor-β (TGF-β) secretion stimulates fibroblasts to transform into myofibroblasts for collagen synthesis, extracellular matrix deposition, and eventual silicosis fibrosis formation [16]. The inhibited activity of autophagy has been observed in TGF-β-treated fibroblasts. MiR-449a induced autophagy activity and reduced Bcl-2 level in silica-activated fibroblasts or a silicosis mice model [17]. Meanwhile, miR-326 also promotes autophagy activity by targeting polypyrimidine tract-binding protein 1 (PTBP1) [18]. Their over-expression alleviated both the distribution and severity of lung lesions. HECT domain-containing protein 1 (HECTD1) is an E3 ubiquitin-protein, which has been proven to be involved in functional cellular changes in silicosis. Either circHECTD1 over-expression or HECTD1 knockdown inhibited silica-induced fibroblast activation, proliferation, and migration via regulating the autophagy activity of fibroblasts [19]. In summary, related research concerning non-coding RNA with its targeted protein, which can regulate autophagy activity, may shed new light on the therapeutic methods of silicosis. Moreover, Rho GDP-dissociation inhibitor α (RhoGDIα) knockdown inhibited collagen deposition through promoting apoptosis of myofibroblasts [20]. Overall, unlike AM, related research based on silica-activated fibroblasts or myofibroblasts should promote autophagy or apoptosis to seek promising intervention methods of silicosis. Notably, in this review, we attached much attention to related studies based on AMs and lung epithelial cells (detailed below). They are both critical targeted cells.
2. Autophagy Is an Essential Way of Programmed Cell Death during Silicotic Progression
Autophagic cell death (i.e., autophagy) is named type II programmed cell death. It is a biological phenomenon that exists widely in eukaryotic cells, which has a powerful ability to “digest” the “waste” of cells [21,22]. Existing studies have shown that the mechanism of silica-induced autophagy is quite complex, involving a series of autophagy-related signaling pathways and regulatory proteins (Figure 1). That understanding of how these signals are linked to silica-induced autophagy may further improve treatment therapies for silicosis.
2.1. Autophagy Plays a Complex Role during the Development of Silicosis via Involvement in Multiple Signaling Pathways
Silica has been proven to regulate autophagy activity via the phosphatidylinositol 3 kinase (PI3K)/protein kinase B (PKB/Akt)/mammalian target of rapamycin (mTOR) signaling pathway. Recent studies have shown that, through the utilization of mTOR inhibitor rapamycin (Rapa), autophagy alleviates silica-induced AM apoptosis [23]. Meanwhile, autophagy reduces the expression of tumor necrosis factor-α (TNF-α) and TGF-β in AMs treated with silica [24]. On the one hand, these findings suggest that the activation of AM autophagy can protect against the silica-induced excessive cell apoptosis or inflammatory response. On the other hand, an mTOR signaling pathway may be a critical point for the mechanism of autophagy. Especially, an active ingredient of the natural plant Atractylodes macrocephala Koidz, Atractylenolide III (ATL-III), accelerated the process of autophagic degradation via fostering the mTOR-dependent signaling pathway [25]. ATL-III may be the potential natural mTOR activator that has been discovered. Therefore, the development of natural or synthetic drugs targeting mTOR may be a promising method for silicosis treatment in clinical settings.
As described, the basic autophagy level has a compensatory protective function for silica invasion; however, cells seem to have the ability to sense the stress caused by silica, which further leads to dysregulation of related signaling pathways and even cell death via the abnormal occurrence of autophagy. Accumulated autophagosomes and damaged lysosomes in the AM of silicosis patients have been observed previously [26], implying that silica disrupts the normal process of AM autophagic degradation. This may be an indispensable feature of abnormal autophagy caused by excessive silica invasion. Moreover, mitophagy also participates in the mechanism of the silica-induced pulmonary toxic effect. When invading the alveoli, silica-activated AM produces mitochondria ROS (mtROS), reduces ATP contents, and breaks mitochondria function. In response to such pathological pulmonary damage, the expression of PINK and Parkin is decreased, which are regulated by BECN1. Meanwhile, the deficiency of BECN1, targeted by microRNA-1224-5p, triggered mitophagy disruption under silica circumstances [27]. Furthermore, dioscin, the main ingredient of Dioscoreaceae, eliminated damaged mitochondria via protecting impaired mitophagy against silica attack [23,28].
Gram-negative bacteria exist in the Chinese mine working environment widely. Correspondingly, lipopolysaccharide (LPS) has been detected in the bronchoalveolar lavage fluid of silicosis patients. LPS further intensifies the blockade of AM autophagic degradation of silicosis patients via the activation of toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88) and the toll-like receptor adaptor molecule 1 (TLRAM1) signaling pathway or inhibition of mTOR signaling pathway [26]. Surprisingly, extensive research has demonstrated that the lung of a healthy body is in a microbial flora balance instead of being “aseptic” [29,30]. In the future, more importance should be attached to the pulmonary toxic effect induced by silica combined with LPS or other classical bacterial flora. It can be speculated that LPS, the vital component of Gram-negative bacteria, may reflect the complex components of the actual working environment to some extent.
2.2. Several Proteins Have Been Proven to Participate in the Regulation of Silica-Induced Autophagy
Accumulating evidence has shown that some CCCH zinc finger protein family members have been discovered to have a potential regulatory function for autophagy induced by silica. For instance, after silica treatment, monocyte chemoattractant protein-1-induced protein 1 (MCPIP1) activated macrophage autophagy activity, further aggravating the silicosis progression through the p53 signaling pathway. Meanwhile, MCPIP1-siRNA reversed silica-induced autophagy and apoptosis of macrophages [31,32]. Like MCPIP1, zinc finger CCCH-type containing 4 protein (ZC3H4) greatly encouraged the autophagy level, further affecting epithelial-mesenchymal transition (EMT) in endothelial cells [33,34,35]. Concretely, ZC3H4 can be activated in multiple ways: (1) the competitive combination of circZC3H4 and miR-212 [36]; (2) the transcription of ZC3H4 mRNA (which may be caused by phosphorylation of Ets-like protein-1 (Elk-1)) [37]. Taken together, ZC3H4 with its related upstream regulators may be useful as a novel autophagy regulatory target for silicosis intervention. Furthermore, an increased secretion of growth arrest-specific protein 6 (Gas6) and its typical receptor Mer has been observed in the bronchoalveolar lavage fluid of the silicosis mice model [38]. Furthermore, the destruction of autophagic degradation was ameliorated in Gas6−/− or Mer−/− mice exposed to silica [39]. Overall, these discovered proteins involved in the autophagy regulation may provide a new idea for treating silicosis patients.
2.3. The Complex Components of the Actual Environment Exposed to Silica Dust Is Still Being Explored
In addition to LPS, there has been an increasing interest in other “stimuli” in the workplace under silica circumstances. Compared to those with a low smoking index or no smoking, the AMs of silicosis patients with a high smoking index had a greater level of autophagic degradation disruption [40]. Furthermore, nicotine, the main ingredient of smoking, accelerated the disrupted autophagic degradation, leading to AM apoptosis finally [41]. Therefore, the prohibition of tobacco smoke or secondhand smoke may also be necessary as a “safeguard” for workers exposed to silica [42].
Intriguingly, Fe atoms were found to be accumulated on the surface of silica. Their size and number were increased with the aggravation of pathological changes of the silicosis rat model. Meanwhile, sequestosome1 (SQSTM1/p62) was accumulated around the silica while not expressed in control mice [43]. Thus, the normal silicosis animal model constructed by single-crystalline SiO2 may not be appropriate. More attention should be paid to the combined pulmonary toxicity by SiO2 and its surface adsorbent. The relationship between these exogenous stimuli and autophagy in the pathological development of silicotic fibrosis should be examined deeply.
2.4. The Process of Autophagic Degradation, Not Autophagy Activity, Should Be Given More Focus during the Process of Silica-Induced Autophagy
Accumulating studies seem to suggest that the change of autophagy activity fails to explain the role that autophagy plays in silica-induced pulmonary fibrosis. For instance, dioscin might delay the progression of silicosis via the activation of autophagy to eliminate damaged mitochondria [23,28]. However, enhanced autophagy activity aggravated silica-induced macrophage apoptosis in the MCPIP1 deficiency of mice. Herein, we support a hypothesis: the degree of autophagic degradation, not the change of autophagy activity, may better reflect the autophagy regulatory mechanism of certain endogenous or exogenous substances in silicotic fibrosis. Correspondingly, many natural products have attracted much attention in studies of pulmonary fibrosis [44]. They may also be protective anti-fibrotic components of silicosis by targeting autophagic degradation, such as ATL-III, dioscin, trehalose (tre, a non-reducing disaccharide), and kaempferol (kae, a flavonoid that exists in many plants and fruits) [23,45,46]. In the future, the molecular mechanism of some natural products with autophagic regulation should be taken as the starting point for exploring the interventions for silicosis.
3. Apoptosis and Pyroptosis Are Both Associated with Toxic Effects Induced by Silica
The apoptosis occurring at an early stage of the silicosis progression has a compensatory function to clear up injured cells and inflammation, assisting in the lung tissue remodeling. However, when AM has a failed phagocytosis or abnormalities in the clearance of the apoptotic AMs, the level of AM apoptosis will escalate gradually, aggravating silicotic fibrosis eventually [47]. Additionally, pyroptosis is a way of host cell death recently discovered, whose stimulating factors include microbial infection, damage-associated molecular pattern, products of ischemic necrosis, etc. Typically, LRR and PYD domains-containing protein 3 (NALP3) combines with apoptosis-associated speck-like protein containing a CARD (ASC) through PYD domains. The NALP3-ASC complex propels caspase-1 to execute pyroptosis. Particularly, pyroptosis is essentially cell inflammatory necrosis mediated by gasdermin D (GSDMD) [48,49,50]. Recent evidence suggests that silica may also be a “red flag” for stimulating cell pyroptosis on a pathological level [51]. This review summarizes the current molecular mechanism of silica-induced apoptosis or pyroptosis (Figure 2).
3.1. Silica-Induced Cell Apoptosis Can Be Mediated by Intrinsic or Exogenous Signaling Pathways
Normally, silica boosts mitochondria to produce mtROS and releases cytochrome c (cyto-c) [52,53]. Cyto-c binds apoptotic protease activating factor-1 (Apaf-1) to initiate a caspase cascade reaction: the cyto-c/Apaf-1 complex activates caspase-9 (not caspase-8) then caspase-3, and the latter can crack poly ADP-ribose polymerase (PARP), further leading to DNA fragmentation (a characteristic of cell apoptosis) [47]. In addition, the interaction between TNF receptor 1 (TNFR1) and NADPH oxidase (Phox) may reduce the mtROS production, alleviating macrophage apoptosis [54]. Our previous study had found that the decreased ratio of Bcl-2/Bax resulted in the caspase-3 activation in the silicosis mice model [55,56]. Moreover, mitochondria-mediated apoptosis occurred in mouse macrophage line MH-S cells with silica exposure, which manifested as the appearance of subdiploid cell fragments, accompanied by the activation of caspase-3 and caspase-9 [57]. The caspase-3 expression was also enhanced in LPS-intervened AMs of silicosis patients or silicosis mice lung tissue [26,58], suggesting that caspase-3 might be a critical center factor during cell apoptosis progress in silicosis. Notably, N-acetylcysteine (NAC) might alleviate the progression of silicosis via regulating the mitochondria-mediated apoptotic pathway [59].
In addition to the intrinsic apoptotic signaling pathway, the Fas/FasL signaling pathway is also one of the major pathways that regulates apoptosis [60]. Fas and the related death-ligand FasL combination can trigger the polymerization of Fas monomers into Fas trimer complexes, and the latter executes cell apoptosis through its death domain [61]. Fas and TNF-α expression in AMs from silicosis patients were significantly higher than those from healthy volunteers or observed objects [62,63]. Another study showed that comparing normal silicotic mice, the FasL−/− silicotic mice did not exhibit obvious inflammatory injury. Furthermore, treatment with anti-FasL Antibodies inhibited the release of TNF-α in the AMs of a silicosis mice model [64]. Simultaneously, annexin A5 may be an upstream protein of Fas/FasL apoptotic pathways, promoting macrophage activation in silica-induced lung fibrosis [65]. In brief, the intrinsic or exogenous pathways both play a crucial role in silica-induced cell apoptosis. Future research should focus on the related molecular mechanism.
3.2. p53 and Its Family Member May Be a Critical Regulator in the Silica-Induced Cell Apoptotic Process
Many investigators have demonstrated that p53 may participate in silica-induced cell apoptosis. Specifically, silica promoted p53 trans-activation through ser-392 p53 phosphorylation and p53 accumulation in embryo fibroblasts [66,67]. Interestingly, the relationship among plasminogen activator inhibitor-1 (PAI-1), urokinase-type plasminogen activator (uPA), and p53 in pulmonary fibrosis has attracted much attention [68,69]. Silica-induced p53 accumulation not only activated PAI-1 expression, but also inhibited uPA expression, inducing apoptosis of lung epithelial cells. Correspondingly, the deficiency of p53 or PAI-1 alleviated cell apoptosis in silica-exposed mice [70]. However, there is no interference among p53 trans-activation, uPA mRNA, and PAI-1 mRNA [71]. These results above suggest that inhibition of p53 expression alone or disruption of p53-fibrinolytic system crosstalk may serve as a novel intervention strategy to prevent silicosis.
PPP1R13B, a major member of the apoptosis-stimulating proteins of the p53 family, may perform an anti-apoptosis function through alleviating endoplasmic reticulum (ER) stress [72,73]. Moreover, a study has shown that continuous silica invasion leads to A549 cell apoptosis induced by excessive ER stress, reflected in the phosphorylation of protein kinase RNA-like endoplasmic reticulum kinase (PERK), eukaryotic initiation factor α (eIF2α), and the up-regulation of CHOP and Caspase-12. Intriguingly, N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP), a physiological regulatory peptide factor, may alleviate A549 cell apoptosis via the PERK/eIF2α/CHOP signaling pathway [74].
3.3. Other Cytokines Form a Complex Apoptotic Network in Silicosis
Currently, the pathological effects of the nuclear factor kappa-B (NF-κB) and TNF-α in silica-induced apoptosis remain controversial. TNF-α has been recognized as a biomarker for the early diagnosis of silicosis [75]. The enhanced TNF-α production was observed in macrophages in response to silica activation, fostering macrophage apoptosis. Furthermore, anti-TNF-α antibodies or soluble TNF receptors improved pulmonary fibrosis in silica-exposed mice [76,77,78]. Silica was able to induce TNF-α transcription via the NF-κB activation. TNF-α also stimulated the NF-κB signaling pathway to protect the cell apoptosis against silica invasion in RAW 264.7 murine macrophages. Such a mechanism may be compensatory protection for lung tissue damage. However, excessive cell apoptosis and pulmonary inflammatory response occur with the over-activation of NF-κB [79,80]. Therefore, antagonism of TNF-α may not constitute an appropriate clinical target in silicosis. The balance between NF-κB activity and TNF-α expression may decide the degree of cell apoptosis and cell fate. Future research should consider the bidirectional role of TNF-α in silica-induced apoptosis more carefully.
It has been recognized that silica-activated AMs release many cytokines, like TNF-α, interleukin-1β (IL-1β), and IL-6, etc. [55], which is the basis of silicosis fibrosis. Among them, IL-1β not only induces an inflammatory response, but regulates macrophage apoptosis [8]. Specifically, IL-1β activated inducible nitric oxide synthase (iNOS), thereby promoting nitric oxide (NO) production, which was also a critical substance to induce apoptosis [81]. Notably, the Fas/FasL can release IL-1β and TNF-α [82,83], implying that the crosstalk between the apoptotic mechanism and cytokine release remains to be elucidated in more detail.
3.4. Silica Is Also an “Irritant” for the Execution of Cell Pyroptosis
NLRP3 and its downstream factors, caspase-1, IL-1β, and IL-18, were greatly expressed in the lung tissue of rats with silicosis [84], while the inhibition or deficiency of NLRP3 alleviated EMT in lung epithelial cells or inflammation in macrophages [85,86]. These findings confirm the view that silica may promote caspase-1 to selectively cleave pro-IL-1β to mature IL-1β, thereby inducing cell death via the pyroptotic pathway [87,88]. Furthermore, bone marrow mesenchymal stem/stromal cells (BMSCs) transplantation may have a potential anti-fibrotic effect for silicosis [89,90,91]. BMSC treatment attenuated NLRP3 and caspase-1 expression, relieving lung inflammatory infiltrates and collagen deposition effectively in the silicosis rat model. Additionally, the levels of BECN1, microtubule-associated protein 1 light chain 3 (LC3), and p62 did not change obviously in this study, implying that autophagy is not associated with the potential anti-silicotic effect of BMSC transplantation [92]. On the contrary, another study indicated that LC3 and BECN1 were decreased in the silicosis rat model with BMSCs. It indicates that the mitigation of pulmonary tissue damage may be caused by the inhibition of autophagy activity [93]. Such an opposite conclusion may be due to the difference in the administration time and dosage of BMSCs. The significance of autophagy, pyroptosis, and BMSCs in the progression of silicosis is still an issue for future research to explore.
However, contrary to the view above, some researchers have supported a proposal that silica alone did not activate NRLP3 inflammasome-directed pyroptosis, because IL-1β release did not change dramatically, although caspase-1 is activated in AM with a single SiO2. Meanwhile, NLRP3 activation, subsequent ASC oligomerization, and caspase-1 activation were observed in AM with LPS priors to silica treatment. The reason may be that NLRP3 expression requires priming with microbial ligands such as LPS or endogenous cytokines, not inducing IL-1β release in unprimed macrophages. Furthermore, docosahexaenoic acid (DHA) inhibited cell pyroptosis in silica-activated AMs treated with LPS [94,95]. In summary, whether single or combined silica can induce pyroptosis in silicosis fibrosis still needs to be further explored. The significance behind this may reflect that the components of silica in an actual working environment are much more complicated than imagined.
4. The Crosstalk among Autophagy, Apoptosis, and Pyroptosis in Silicotic Fibrosis Needs to Be Further Discussed
As described before, autophagy can act as an enabler or antagonist of apoptosis to impede or promote cell survival [96]. Moreover, there is the crosstalk that exists between autophagy and apoptosis. Bcl-2 is a critical anti-apoptotic protein in silica-induced autophagy. The formation of the BECN1-PIK3C3 complex is quite essential for the extension of the autophagosome bilayer membrane, while Bcl-2 binds to BECN1 then inhibits the interaction of BECN1 and PI3KC3 or the phosphorylation of PI3KC3 [97]. A study has demonstrated that silica induces the BECN1–PIK3C3 complex but reduces the BECN1–Bcl-2 complex, further escalating autophagy level [98]. Moreover, Bcl-2-binding component 3 (BBC3), a potent activator of apoptosis that also belongs to the Bcl-2 family [99], may inhibit the binding of BECN1 and Bcl-2 competitively, thereby facilitating silica-induced macrophage autophagy activity [100]. In addition, a widely accepted stimulating factor to mediate apoptosis, ER stress, may also stimulate autophagy activity in the development of silicosis, caused by the excessive accumulation of unfolded proteins in the endoplasmic reticulum [33,101].
Admittedly, there is also an interaction between autophagy and pyroptosis (Figure 3). NALP3, IL-1β, and caspase-1 were activated via lysosomal disruption caused by macrophage phagocytosis for silica [102]. Furthermore, the deficiency of autophagy by Atg5 knockout activated NLRP3 inflammasome activity [103]. These findings indicate that pyroptosis may be closely associated with autophagy. Meanwhile, like apoptosis, pyroptosis is also a critical pathological process in silicosis. In the future, silica-induced pyroptosis can be regarded as an indicator together with apoptosis in the studies of the autophagy-related mechanism to reflect the silicosis progression. In addition to apoptosis, it is further possible that caspase-3 can cleave the GSMDE N-terminal fragment, which forms pores on the plasma membrane to mediate pyroptosis [104,105]. Therefore, it will be desirable in future studies to investigate the relationship between caspase-3 and pyroptosis during the development of silicosis.
5. Conclusions
Silicosis has been a severe occupational hazard disease until now. The proposed hypothesis cannot explain the pathological mechanism of silicosis perfectly, even though it has been gradually elucidated. From the perspective of programmed cell death, we summarized an amount of autophagic or apoptotic signaling pathways or regulatory proteins in silicosis pathogenesis. Moreover, as a “dangerous flag”, silica can also exacerbate pyroptosis. Herein, we proposed some views: (1) The blockade of autophagic degradation is characteristic of abnormal autophagy caused by silica. The degree of the blockade of autophagic degradation, not autophagy activity, may reflect positive or negative effects of autophagy on silicosis better when discussing the function of the exogenous toxic substance or potential protective agent on silica-induced autophagy; (2) Silicotic progression depends on the combined effect of silica and exogenous irritants, not silica alone. Furthermore, the silicosis animal or cell model should be established more cautiously due to the complex composition of silica; (3) Many related mechanisms, like the bidirectional effect of TNF-α in silica-induced apoptosis, or the regulatory function by caspase-3 on pyroptosis deserves further discussion; (4) Pyroptosis may be a potential mechanism during the development of silicosis, and it should also be regarded as an “outcome variable” to assess the severity of pathological changes in silicosis. As also recommended above, these opinions above may provide some promising enlightenment for future interventions or treatment for silicosis.
Author Contributions
All authors contributed in the literature search writing and design of the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding
This work was supported by the National Natural Science Foundation of China (No. 81703199), the Natural Science Foundation of Hunan Province (No. 2019JJ50398), the Key Project of Hunan provincial science and technology innovation (NO. 2020SK1015-3), and the Hunan Normal University undergraduates innovative experiment project and entrepreneurship program (2019116).
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Abbreviations
| Ac-SDKP | N-acetyl-seryl-aspartyl-lysyl-proline |
| AM | Alveolar macrophage |
| Apaf-1 | Apoptotic protease activating factor-1 |
| ASC | Apoptosis-associated speck-like protein containing a CARD |
| ATL-III | Atractylenolide III |
| BBC3 | Bcl-2-binding component 3 (BBC3) |
| BMSCs | Bone marrow mesenchymal stem/stromal cells (BMSCs) |
| Cyto-c | Cytochrome c |
| DHA | Docosahexaenoic acid |
| eIF2α | eukaryotic initiation factor α |
| Elk-1 | Ets-like protein-1 (Elk-1) |
| EMT | Epithelial-mesenchymal transition |
| ER | Endoplasmic reticulum |
| Gas6 | Growth arrest-specific protein 6 |
| GSDMD | Gasdermin D |
| HECTD1 | HECT domain-containing protein 1 |
| IL-1β | Interleukin-1β |
| iNOS | Inducible nitric oxide synthase |
| Kea | Kaempferol |
| LC3 | Microtubule-associated protein 1 light chain 3 |
| LPS | Lipopolysaccharide |
| MCPIP1 | Monocyte chemoattractant protein-1-induced protein 1 |
| mTOR | mammalian target of rapamycin |
| mtROS | mitochondria ROS |
| MyD88 | Myeloid differentiation factor 88 |
| NAC | N-acetylcysteine |
| NALP3 | LRR and PYD domains-containing protein 3 |
| NF-κB | Nuclear factor kappa-B |
| NO | Nitric oxide |
| PAI-1 | Plasminogen activator inhibitor-1 |
| PARP | Poly ADP-ribose polymerase |
| PCD | Programmed cell death |
| PERK | Protein kinase RNA-like endoplasmic reticulum kinase |
| Phox | NADPH oxidase |
| PI3K | Phosphatidylinositol 3 kinase |
| PKB/Akt | Protein kinase B |
| PTBP1 | Polypyrimidine tract-binding protein 1 |
| Rapa | Rapamycin |
| RhoGDIα | Rho GDP-dissociation inhibitor α |
| SQSTM1/p62 | Sequestosome1 |
| TGF-β | Transforming growth factor-β |
| TLR4 | Toll-like receptor 4 |
| TLRAM1 | Toll-like receptor adaptor molecule 1 |
| TNF-α | Tumor necrosis factor-α |
| TNFR1 | TNF receptor 1 |
| Tre | Trehalose |
| uPA | urokinase-type plasminogen activator |
| ZC3H4 | Zinc finger CCCH-type containing 4 protein |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Enlarge this image.Figure 1. Related molecular mechanisms and effects during the process of silica-induced autophagy. Silica invasion led to the accumulation of autophagosomes and the disruption of lysosomes, thereby breaking the function of autophagic degradation through the PI3K/Akt/mTOR signaling pathway. Under silica circumstances, ZC3H4 and MCPIP1 both activated autophagy activity. Concretely, ZC3H4 was enhanced not only by the up-regulation of circZC3H4, but also by the transcription of ZC3H4 mRNA via phosphorylation of Elk-1. Furthermore, the interaction of Gas6 and its receptor, Mer, boosted autophagy activity. In addition, Fe atoms were found to be accumulated on the surface of silica, which further magnified the pathological damage of the autophagic process. LPS, nicotine, and habitual smoking all led to the blockade of autophagic degradation. Specifically, TLR4/Myd88 or TLR4/TICAM signaling pathways might be involved in the autophagy induced by silica together with LPS. Particularly, natural products like tre and kea had a protective function in the degradation process of autophagic substrates. When silica invaded, dioscin removed redundant damaged mitochondria through AM mitophagy, and ATL-III protected AM autophagic degradation via an mTOR-dependent signaling pathway.
Enlarge this image.Figure 2. A complex regulatory network of initiation of silica-induced apoptosis or pyroptosis. Normally, when silica invades the alveoli, mtROS is produced and augments the formation of the cas-9-Apaf-1 complex. Furthermore, cas-3 is activated to crack PARP, leading to cell apoptosis finally. In such a mitochondrial-dependent apoptotic pathway, the increased ratio of Bax/Bcl-2 aggravates the cas-3 activation. Moreover, the Fas/FasL signaling pathway, induced by upstream factor Annexin A5, also mediates silica-induced apoptosis. p53 induces apoptosis, not via the inhibition of uPA and induction of PAI-1, but via p53 trans-activation. Another member of the p53 family, PPP1R13B, promotes over-activation of ER stress via the PERK/eIF2α/CHOP signaling pathway, further initiating silica-induced apoptosis. Similarly, it also can be activated by ER stress-related protein cas-12. Silica-induced apoptosis is still induced by the IL-1β-iNOS-NO cascade reaction. Notably, TNF-α activation aggravates cell apoptosis. However, TNF-α also stimulates the NF-κB signaling pathway to alleviate cell apoptosis against silica invasion. The bidirectional role of TNF-α deserves further discussion. It is worth noting that NAC and DHA have potential anti-apoptotic effects activated by silica. In addition to apoptosis, silica can stimulate the interaction of NALP3 and ASC, and subsequent NALP3-ASC complex activates cas-1. The cas-1 activation leads to the transformation from pro-IL-1β to IL-1β, further executing cell pyroptosis. BMSCs might mitigate cell pyroptosis via inhibition of NALP3.
Enlarge this image.Figure 3. The current molecular mechanism of crosstalk among autophagy, apoptosis, and pyroptosis under silica circumstances. Two important members of the Bcl-2 apoptotic protein family, Bcl-2 and BBC3, activate autophagy via reducing the Bcl-2–BECN1 complex in silica-induced pulmonary fibrosis. Autophagy activity is also stimulated by silica-induced ER stress. Lysosomal disruption, a critical characteristic of silica-induced autophagy, could foster the formation of the NALP3–ASC complex. It further activates cas-1, boosting the transformation from pro-IL-1β to IL-1β and executing pyroptosis. Notably, the relationship between autophagy and NALP3 or the mechanism of cas-3-mediated pyroptosis deserves more exploration.
© 2021 by the authors.